Late toxicity and biochemical control in 554 prostate cancer patients treated with and without dose escalated image guided radiotherapy

Despite dose escalation, the use of FMIGRT in radical radiotherapy for prostate cancer significantly reduces the incidence of gastrointestinal toxicity and the duration of late genitourinary toxicity when compared to conventional non-FMIGRT techniques.